Clinical Study on Autosomal Dominant Polycystic Kidney Disease among South Indians

P. Veeramuthumari, W. Isabel

PG & Research Department of Zoology & Biotechnology, Lady Doak College, Madurai, India.

DOI: 10.4236/ijcm.2013.44035                

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited disorder in humans, with a frequency of 1 in 100 in the general population. ADPKD is caused by mutations in PKD1 gene (85%) located on human chromosome 16p13.3; Mutations in the PKD2 gene contribute to 15% of ADPKD incidence and is located on human chromosome 4q2-23. A total of hundred ADPKD patients and age and sex matched healthy individuals were selected for the study. The study was aimed to evaluate the prevalence of ADPKD, lipid profile and level of calcium (Ca), sodium (Na), iron (Fe) and potassium (K) in patients with ADPKD and in healthy individuals. The lipid profile was analyzed using commercially available span kit and semiautoanalyzer (Erba, Chem 5X). The Ca, Na, Fe and K concentrations were estimated by flame photometry (ELICO, CL 22D) and atomic absorption spectroscopy (ELICO, SL 173) and significant changes were noted at p < 0.05. The ADPKD patients were observed to have lipid abnormalities, hyponatremia, cholesterolemia, renal osteodystrophy, cardiovascular problems and anemia. Therefore, the study reveals an association between the lipid profile and Ca, Na, Fe and K levels with ADPKD among South Indian population.

Keywords

Polycystic Kidney Disease; Hyponatremia; Renal Osteodystrophy; Anemia

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	A. Persu, M. S. Steoenoiu, T. Messiaen, S. Davila, C. Robino, O. El-Khattabi, M. Mourad, S. Horie, O. Feron, J.-L. Balligand, R. Wattiez, Y. Pirson, D. Chauveau, X. M. Lens and O. Devust, “Autosomal Dominant Polycystic Kidney Disease,” Human Molecular Genetics, Vol. 11, No. 3, 2002, pp. 229-241. doi:10.1093/hmg/11.3.229
[2]	P. A. Gabow, “Autosomal Dominant Polycystic Kidney Disease,” The New England Journal of Medicine, Vol. 329, No. 5, 1993, pp. 332-342. doi:10.1056/NEJM199307293290508
[3]	Y. Pei, N. He, K. Wang, M. Kasenda, A. D. Paterson, G. Chan, Y. Liang, J. Roscoe, J. Brissenden, D. Hefferton, P. Parfrey, S. Somlo, S. T. George and P. Hyslop, “A Spectrum of Mutation in Polycystic Kidney Disease—2 (PKD2) Gene from Eight Canadian Kidrede,” Journal of the American Society of Nephrology, Vol. 9, 1998, pp. 1853-1860.
[4]	R. L. Maser, D. Vassmer, B. S. Magenheimer and J. P. Calcet, “Oxidant Stress and Reduced Antioxidant Enzyme Protection in Polycystic Kidney Disease,” Journal of the American Society of Nephrology, Vol. 13, No. 4, 2002, pp. 991-999.
[5]	M. Koptides, C. Hadjimichael, P. Koupepidou and C. C. Deltas, “Germinal and Somatic Mutations in the PKD2 Gene of Renal Cysts in Autosomal Dominant Polycystic Kidney Disease,” Human Molecular Genetics, Vol. 8, No. 3, 1999, pp. 509-513. doi:10.1093/hmg/8.3.509
[6]	M. Koptides, C. Hadjimichael, P. Koupepidou and C. C. Deltas, “Genetic Evidence for a Trans-Heterozygous Model for Cytogenesis in Autosomal Dominant Polycystic Kidney Disease,” Human Molecular Genetics, Vol. 9, No. 3, 2000, pp. 447-452. doi:10.1093/hmg/9.3.447
[7]	B. K. Yoder, X. Hou and L. M. Guay-Woodford, “The Polycystic Kidney Disease Proteins, Polycystin-1, Polycystin-2, Polaris and Cystin, Are Co-Localized in Renal Cilia,” Journal of the American Society of Nephrology, Vol. 13, 2002, pp. 2508-2516. doi:10.1097/01.ASN.0000029587.47950.25
[8]	B. Tazon-Vega, M. Vilardell, L. Perez-Oller, E. Ars, P. Ruiz, O. Devuyst, X. Lens, Fernandez, P. Llama, J. Ballarin and R. Torra, “Study of Candidate Genes Affecting the Progression of Renal Disease in Autosomal Dominant Polycystic Kidney Disease Type 1,” Nephrology Dialysis Transplantation, Vol. 22, No. 6, 2007, pp. 1567-1577. doi:10.1093/ndt/gfm036
[9]	S. Xenophontos, R. Constantinides, T. Hayashi, T. Mochizuki, S. Somlo, A. Pierides and C. C. Delta, “A Translation Frameshift Mutation Induces by a Cytosine Insertion in the Polycystic Kidney Disease 2 gene (PKD2),” Human Molecular Genetics, Vol. 2, 1997, pp. 949-953. doi:10.1093/hmg/6.6.949
[10]	O. Devuyst, A. Persu and M.-T. Vo-Cong, “Autosomal Dominant Polycystic Kidney Disease: Modifier Genes and Endothelial Dysfunction,” Nephrology Dialysis Transplantation, Vol. 18, No. 11, 2003, pp. 2211-2215. doi:10.1093/ndt/gfg351
[11]	S. Rossetti, M. B. Consugar, A. B. Chapman, V. E. Torres, L. M. Guay-Woodford, J. J. Grantham, W. M. Bennett, C. M. Meyers, D. L. Walker, K. Bae, Q. Zhang, P. A. Thompson, P. J. Miller and P. C. Harris, “CRISP Consotium: Comparehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease,” Journal of the American Society of Nephrology, Vol. 18, 2007, pp. 2143-2160. doi:10.1681/ASN.2006121387
[12]	S. Rossetti and P. C. Harris, “Genotype-Phynotype Correlations in Autosomal Dominat and Autosomal Recessive Polycystic Kidney Disease,” Journal of the American Society of Nephrology, Vol. 18, No. 5, 2007, pp. 1374-1380. doi:10.1681/ASN.2007010125
[13]	T. J. Watnick, V. E. Torres, M. A. Gandolph, F. Qian, L. F. Onuchic, K. W. Klinger, G. Landes and G. G. Germino, “Somatic Mutation in Individual Liver Cysts Supports a to Hit Model of Cytogenesis in Autosomal Dominant Polycystic Kidney Disease,” Molecular Cell, Vol. 2, 1998, pp. 247-251. doi:10.1016/S1097-2765(00)80135-5
[14]	C. Boucher and R. Sandford, “Autosomal Dominant Polycystic Kidney Disease (ADPKD, MIM 173900, PKD1 and PKD2 Genes, Protein Products Known as Polycystin1 and Polycystin-2,” European Journal of Human Genetics, Vol. 12, No. 5, 2004, pp. 347-354. doi:10.1038/sj.ejhg.5201162
[15]	R. Torra, M. Viribay, D. Tellaria, C. Badenas, M. Watson, P. Harris, A. Darnell and J. L. San Millan, “Seven Novel Mutations of the PKD2 Gene Families with Autosomal Dominant Polycyctic Kidney Disease,” Kidney International, Vol. 56, No. 1, 1999, pp. 28-33. doi:10.1046/j.1523-1755.1999.00534.x
[16]	P. Igarashi and S. Somlo, “Genetics and Pathogenesis of Polycystic Kidney Disease,” Journal of the American Society of Nephrology, Vol. 13, No. 9, 2002, pp. 2384-2398. doi:10.1097/01.ASN.0000028643.17901.42
[17]	J. Hughes, C. J. Ward, B. Peral, R. Aspinwall, K. Clak, J. L. San Millan, V. Gamble and P. C. Harris, “The Polycystic Kidney Disease 1 (PKD1) Gene Encodes a Novel Protein with Multible Cell Recognition Domains,” Nature Genetics, Vol. 10, 1995, pp. 151-160. doi:10.1038/ng0695-151
[18]	T. C. Burn, T. D. Connors, W. R. Dackowski, L. R. Pertry, T. J. Van Raay, J. M. Millholland, M. Venet, G. Miller, R. M. Hakim, G. M. Landes, K. W. Klinger, F. Qian, et al., “Analysis of the Genomic Sequence for the Autosomal Domiant Polycystic Kideny Disease (PKD1) Gene Predicts the Presence of a Leucine-Rich Repeat,” Human Molecular Genetics, Vol. 4, No. 4, 1995, pp. 575-582. doi:10.1093/hmg/4.4.575
[19]	T. Mochizuki, G. Wu, T. Hayashi, S. Xenophontos, B. Veldhuisen, J. J. Saris, D. Reynolds, Y. Cai, Gabow, A. Pierides, W. Kimberling, M. Breuning, C. Contantinou Deltas, D. Peters and S. Somlo, “PKD2, a Gene for Polycystic Kidney Sidease That Encodes an Integral Membrane Protein,” Science, Vol. 272, No. 5266, 1996, pp. 1339-1342. doi:10.1126/science.272.5266.1339
[20]	C. J. Ward, M. C. Hogan, S. Rossetti, D. Walker, T. Sneddon, X. Wang, V. Kubly, J. M. Cunningham, R. Bacallao, M. Ishibashi, et al., “The Gene Mutated in Autosomal Recessive Polycystic Kidney Disease Encodes a Large, Receptor-Like Protein,” Nature Genetics, Vol. 30, No. 3, 2002, pp. 259-269. doi:10.1038/ng833
[21]	N. Hateboer, B. Veldhusen, D. Peters, M. H. Breuning, M. A. V. Dijk, A. R. Afzal, S. Jeffery, A. K. Saggar-Malik, R. Torra, D. Dimitrakov, I. Matinez, S. Sanz de Castro, M. Krawczak and D. Ravine, “Location of Mutations within the PKD2 Gene Influences Clinical Outcome,” Kidney International, Vol. 57, No. 4, 2000, pp. 1444-1451. doi:10.1046/j.1523-1755.2000.00989.x
[22]	M. Ragab and A. Ragab, “Assement of Lipid Profile in Egyptian Children with Chronic Kidney Diseases on Conservative Therapy and Those under Regular Hemodialysis,” Journal of Medical Sciences, Vol. 7, No. 5, 2007, pp. 825-829. doi:10.3923/jms.2007.825.829
[23]	N. T. de Gómez Dumm, A. M. Giammona, L. A. Touceda and C. Raimondi, “Lipid Abnormalities in Chronic Renal Failure Patients Undergoing Hemodialysis,” Lipid and Health Diseases, Vol. 2, 2003, pp. 1-6.
[24]	R. Trevisan, A. R. Dodesini and G. Lepore, “Lipids and Renal Disease,” Journal of the American Chemical Society, Vol. 17, No. S2, 2006, pp. S145-S147.
[25]	N. T. de Gómez Dumm, A. M. Giammona, L. A. Touceda and C. Raimondi, “Lipid Abnormalities in Chronic Renal Failure Patients Undergoing Hemodialysis,” Medicina (Buenos Aires), Vol. 61, No. 2, 2001, pp. 142-146.
[26]	N. T. de Gómez Dumm, A. M. Giammona and L. A. Touceda, “Variations in the Lipid Profile of Patients with Chronic Renal Failure Treated with Pyridoxine,” Lipid and Health Diseases, Vol. 2, 2003, p. 7.
[27]	A. Cases and E. Coll, “Dyslipidemia and the Progression of Renal Disease in Chronic Renal Failure Patients,” Kidney International, Vol. 68, No. 99, 2005, pp. S87-S93. doi:10.1111/j.1523-1755.2005.09916.x
[28]	L. P. Sullivan, D. P. Wallace and J. J. Grantham, “Epithelial Transport in Polycystic Kidney Disease,” Physiological Reviews, Vol. 78, No. 4, 1998, pp. 1165-1191.
[29]	J. J. Grantham and P. J. Calvet, “Polycystein-2, the Protein Mutated in Autosomal Dominant Polycystic Kidney Disease (ADPKD), Is a Ca2+ Permeable Nonselective Cation Chennel,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 3, 2001, pp. 790-792. doi:10.1073/pnas.98.3.790
[30]	R. Constantinides, S. Xenophoutos, P. Neophyton, S. Nomura, A. Pierides and C. C. Deltas, “New Amino Acid Polymorphism, Ala/Val4058, in Exon 45 of the Polycystic Kidney Disease 1 Gene,” Human Genetics, Vol. 99, No. 5, 1997, pp. 644-647. doi:10.1007/s004390050421
[31]	P. Muntner, J. Coresh, J. C. Smith, et al., “Plasma Lipid and Risk of Developing Renal Dysfunction: The Artherosclerosis Risk in Communities,” Kidney International, Vol. 58, No. 1, 2000, pp. 293-301. doi:10.1046/j.1523-1755.2000.00165.x
[32]	A. E. Grzegprzewska and M. Mlot, “Serum Osteoprotegrin Level Is Lower in Peritoneal Dialysis Patients than in Hemodialysi Ones,” Annal Acad Medcae Bialosto, 2004, p. 49.
[33]	B. Coffin, Hadengue, F. Degos and J.-P. Benhamou, “Calcified Hepatic and Renal Cysts in Adult Dominant Polycystic Kidney Disease,” Digestive Diseases and Sciences, Vol. 15, No. 9, 1999.